Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/14/1995 | WO1995024478A1 Synthetic proteins as implantables |
09/14/1995 | WO1995024477A1 Human papillomavirus targeted ribozymes |
09/14/1995 | WO1995024474A1 Bone morphogenic protein-10 |
09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
09/14/1995 | WO1995024469A1 Extracorporeal cell culture and transplantation kits |
09/14/1995 | WO1995024466A1 Transforming growth factor alpha h1 |
09/14/1995 | WO1995024427A1 Hybrid human/animal factor viii |
09/14/1995 | WO1995024426A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
09/14/1995 | WO1995024425A1 Immunomodulatory trichinella substances |
09/14/1995 | WO1995024424A1 Cyclic peptide lhrh antagonists |
09/14/1995 | WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
09/14/1995 | WO1995024421A1 Peptide derivative |
09/14/1995 | WO1995024418A1 Method of isolating and purifying a biomacromolecule |
09/14/1995 | WO1995024417A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof |
09/14/1995 | WO1995024414A1 Fibroblast growth factor-10 |
09/14/1995 | WO1995024411A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | WO1995024223A1 Inhibition of cell proliferation by e2f-1 antisense oligonucleotides |
09/14/1995 | WO1995024221A1 Bioactive and/or targeted dendrimer conjugates |
09/14/1995 | WO1995024220A1 Bispecific molecules having clinical utilities |
09/14/1995 | WO1995024217A1 Methods for modulating t cell unresponsiveness |
09/14/1995 | WO1995024216A1 Prevention of diabetes |
09/14/1995 | WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin |
09/14/1995 | WO1995024212A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections |
09/14/1995 | WO1995024211A1 Use of fibroblast growth factors to stimulate bone growth |
09/14/1995 | WO1995024210A1 Methods and compositions for treatment of periodontal disease and repair of periodontal lesions |
09/14/1995 | WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
09/14/1995 | WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor |
09/14/1995 | WO1995024207A1 Composition for the treatment of lung disease |
09/14/1995 | WO1995024202A1 Ribozyme therapy for restenosis |
09/14/1995 | WO1995024198A1 DIROFILARIA IMMITIS Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
09/14/1995 | WO1995024183A1 Methods and compositions for pulmonary delivery of insulin |
09/14/1995 | WO1995024182A1 Human osteoclast-derived cathepsin |
09/14/1995 | WO1995015177A3 Improved efficacy of alpha-helical cytokines |
09/14/1995 | DE4408116A1 New viprolide derivs. |
09/14/1995 | CA2443236A1 Human osteoclast-derived cathepsin |
09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
09/14/1995 | CA2185327A1 Hybrid human/animal factor viii |
09/14/1995 | CA2185212A1 Peptide derivatives |
09/14/1995 | CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof |
09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | CA2185027A1 Methods for modulating t cell unresponsiveness |
09/14/1995 | CA2184989A1 Ribozyme therapy for restenosis |
09/14/1995 | CA2184988A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
09/14/1995 | CA2184905A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
09/14/1995 | CA2184686A1 Transgenic production of oligosaccharides and glycoconjugates |
09/14/1995 | CA2184583A1 Transforming growth factor alpha h1 |
09/14/1995 | CA2184498A1 Extracorporeal cell culture and transplantation kits |
09/14/1995 | CA2184385A1 Composition for the treatment of lung disease |
09/14/1995 | CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor |
09/14/1995 | CA2183963A1 Dirofilaria immitis gp29 proteins, nucleic acid molecules and uses thereof |
09/14/1995 | CA2183961A1 Fibroblast growth factor-10 |
09/14/1995 | CA2183898A1 Nucleotide or nucleosidephotoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics |
09/14/1995 | CA2183644A1 Synthetic proteins as implantables |
09/14/1995 | CA2182800A1 Method of stimulating hematopoiesis with hemoglobin |
09/14/1995 | CA2180353A1 Antimicrobial proteins from aralia and impatiens |
09/13/1995 | EP0671472A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
09/13/1995 | EP0671470A2 Trehalose releasing enzyme, DNA encoding therefor, their preparation and uses |
09/13/1995 | EP0671414A1 Antithrombotic |
09/13/1995 | EP0671413A1 Somatostatin analogs for preventing NSAID-induced ulcers |
09/13/1995 | EP0671412A1 Tumor cell invasion-inhibiting peptides and cancer metastasis inhibitors |
09/13/1995 | EP0671390A2 Antithrombotic agents |
09/13/1995 | EP0671165A2 Collagen-based injectable drug delivery system and its use |
09/13/1995 | EP0671161A1 Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation |
09/13/1995 | EP0671004A1 Allergen/inflammatory testing and diagnosis |
09/13/1995 | EP0670904A1 Vector for the expression of therapy-relevant genes |
09/13/1995 | EP0670899A1 Heat shock proteins and the treatment of tumours |
09/13/1995 | EP0670898A1 Interleukin-3 (il-3) mutant polypeptides |
09/13/1995 | EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
09/13/1995 | EP0670896A1 Cloning and expression of biologically active alpha-galactosidase a |
09/13/1995 | EP0670895A1 Cloning, expression and uses of a novel secreted protein, f-spondin |
09/13/1995 | EP0670848A1 High molecular weight collagen-like protein polymers |
09/13/1995 | EP0670847A1 Subtilin variant of enhanced stability and activity |
09/13/1995 | EP0670738A1 Methods for enhancing vascularization of implant devices |
09/13/1995 | EP0670737A1 In vivo peptide therapy |
09/13/1995 | EP0670734A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
09/13/1995 | EP0670733A1 Compositions containing growth factors and antiplastic agents |
09/13/1995 | EP0670732A1 Compositions containing growth factors and antimetabolites |
09/13/1995 | EP0670731A1 AMELIORATION OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY DEPOSITION OF AMYLOID $g(b) PROTEIN |
09/13/1995 | EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor |
09/13/1995 | EP0670729A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
09/13/1995 | EP0670728A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
09/13/1995 | EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same |
09/13/1995 | EP0670711A1 Mouthcare compositions |
09/13/1995 | EP0542869B1 Tissue plasminogen activator variants with decreased clearance |
09/13/1995 | EP0475936B1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
09/13/1995 | EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides |
09/13/1995 | CN1108261A New pseudopeptides having an antiviral action |
09/13/1995 | CN1108138A Pharmaceutical using of bradykinin-antagonist in preparation of drug for treating viral illness |
09/13/1995 | CN1108137A Pharmaceutical compositions |
09/12/1995 | US5449798 Phospholipid derivatives containing higher elements of the fifth group |
09/12/1995 | US5449778 Peptide intermediates |
09/12/1995 | US5449766 DNA encoding NEI and NGE peptides |
09/12/1995 | US5449765 DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus |
09/12/1995 | US5449760 Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
09/12/1995 | US5449759 Hemoglobins with intersubunit desulfide bonds |
09/12/1995 | US5449757 Mammalian adipogenic factors |
09/12/1995 | US5449755 Human cyclin E |
09/12/1995 | US5449753 Autotaxin: motility stimulating protein useful in cancer diagnosis |
09/12/1995 | US5449752 Polypeptides with affinity to lipopolysaccharides and their uses |